Literature DB >> 6237928

Uptake and stability of human and bovine acid alpha-glucosidase in cultured fibroblasts and skeletal muscle cells from glycogenosis type II patients.

A J Reuser, M A Kroos, N J Ponne, R A Wolterman, M C Loonen, H F Busch, W J Visser, P A Bolhuis.   

Abstract

Acid alpha-glucosidase (EC 3.2.1.20) was purified from human placenta and bovine testis by affinity chromatography using concanavalin A (conA) and Sephadex G 200. When added to the culture medium of human fibroblasts, the enzyme purified from bovine testis is taken up with a 200-fold higher efficiency than the enzyme from human placenta. Uptake of acid alpha-glucosidase from bovine testis is mediated by the mannose-6-phosphate receptor, whereas only a minor fraction of placental enzyme appears to be equipped with the mannose-6-phosphate recognition marker. Once internalized, both human and bovine acid alpha-glucosidase demonstrate a half-life of about 10 days in fibroblasts from control individuals and patients with different clinical forms of glycogenosis type II (Pompe's disease, acid alpha-glucosidase deficiency). Evidence is presented that the mannose-6-phosphate receptor is also present on the plasma membrane of the clonal myogenic skeletal muscle cell lines G8-1 and L6J1 (respectively from mouse and rat origin) and on cultured human skeletal muscle cells derived from a muscle biopsy. Addition of bovine testis acid alpha-glucosidase to skeletal muscle cell cultures from an adult patient with glycogenosis type II leads to complete correction of the enzyme deficiency.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237928     DOI: 10.1016/0014-4827(84)90779-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

Review 2.  Challenges in treating Pompe disease: an industry perspective.

Authors:  Hung V Do; Richie Khanna; Russell Gotschall
Journal:  Ann Transl Med       Date:  2019-07

3.  Monoclonal antibody to human lysosomal alpha-glucosidase in immunocytochemistry: unexpected reactivity with cytoskeletal structures.

Authors:  H J Sips; N De Jonge; H M Van Dongen; F C Ramaekers; A J Reuser
Journal:  Histochem J       Date:  1985-09

4.  Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells.

Authors:  A T van der Ploeg; P A Bolhuis; R A Wolterman; J W Visser; M C Loonen; H F Busch; A J Reuser
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

5.  Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease.

Authors:  Tokiko Fukuda; Meghan Ahearn; Ashley Roberts; Robert J Mattaliano; Kristien Zaal; Evelyn Ralston; Paul H Plotz; Nina Raben
Journal:  Mol Ther       Date:  2006-09-27       Impact factor: 11.454

6.  A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes.

Authors:  Petra Tiels; Ekaterina Baranova; Kathleen Piens; Charlotte De Visscher; Gwenda Pynaert; Wim Nerinckx; Jan Stout; Franck Fudalej; Paco Hulpiau; Simon Tännler; Steven Geysens; Annelies Van Hecke; Albena Valevska; Wouter Vervecken; Han Remaut; Nico Callewaert
Journal:  Nat Biotechnol       Date:  2012-11-18       Impact factor: 54.908

7.  High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease.

Authors:  J L Van Hove; H W Yang; J Y Wu; R O Brady; Y T Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

8.  Long-term effects of bone marrow transplantation on lysosomal enzyme replacement in beta-glucuronidase-deficient mice.

Authors:  G Bou-Gharios; G Adams; P Pace; I Olsen
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

9.  Lipidic Nanoparticles Comprising Phosphatidylinositol Mitigate Immunogenicity and Improve Efficacy of Recombinant Human Acid Alpha-Glucosidase in a Murine Model of Pompe Disease.

Authors:  Jennifer L Schneider; Robert K Dingman; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2017-11-02       Impact factor: 3.534

10.  Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice.

Authors:  A T Van der Ploeg; M A Kroos; R Willemsen; N H Brons; A J Reuser
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.